Ibutilide in Rapid Conversion of Atrial Flutter in Octogenarians

作者: Roberto Antonicelli , Paolo Testarmata , Andrea Recanatini

DOI: 10.2165/00002512-200219100-00007

关键词:

摘要: Introduction: Atrial flutter is a common sustained atrial tachyarrhythmia for which frequency increases with age. Ibutilide novel class III antiarrhythmic agent used the rapid cardioversion of fibrillation or flutter. Aim: The aim our study was to assess use ibutilide in selected population very elderly patients (octogenarians) recent-onset Method: Twenty-nine consecutive (11 male, 18 female; mean age 83 ± 3 years; interquartile range 10) were included study; none them had signs symptoms severe heart failure, angina impaired renal hepatic function. All underwent 10-minute intravenous infusion (0.87mg 10ml). Results: rate successful arrhythmia termination 75.9% within time 31 20 minutes. No clinical variables shown be associated cardioversion, although there tendency towards higher efficacy shorter duration arrhythmia. Two female (6.9%) developed torsade de pointes, requiring direct current under general anaesthesia. Episodes nonsustained ventricular tachycardia occurred two other patients. Conclusion: appears an effective and well tolerated drug conversion octogenarian patients, may represent valid approach acute management this particular set

参考文章(25)
Kenneth A. Ellenbogen, Bruce S. Stambler, Mark A. Wood, Philip T. Sager, Robert C. Wesley, Marc D. Meissner, Robert G. Zoble, Linda K. Wakefield, Kimberly T. Perry, James T. Vanderlugtt, Ibutilide Investigators, Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study Journal of the American College of Cardiology. ,vol. 28, pp. 130- 136 ,(1996) , 10.1016/0735-1097(96)00121-0
Bruce S. Stambler, Mark A. Wood, Kenneth A. Ellenbogen, Kimberly T. Perry, Linda K. Wakefield, James T. VanderLugt, Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation Circulation. ,vol. 94, pp. 1613- 1621 ,(1996) , 10.1161/01.CIR.94.7.1613
Jonathan M. Kalman, Jeffrey E. Olgin, Leslie A. Saxon, Westby G. Fisher, Randall J. Lee, Michael D. Lesh, Activation and Entrainment Mapping Defines the Tricuspid Annulus as the Anterior Barrier in Typical Atrial Flutter Circulation. ,vol. 94, pp. 398- 406 ,(1996) , 10.1161/01.CIR.94.3.398
Kelly C Rogers, Douglas A Wolfe, Ibutilide: A class III rapidly acting antidysrhythmic for atrial fibrillation or atrial flutter Journal of Emergency Medicine. ,vol. 20, pp. 67- 71 ,(2001) , 10.1016/S0736-4679(00)00274-2
Brian Olshansky, Ken Okumura, Paul G. Hess, Albert L. Waldo, Demonstration of an area of slow conduction in atrial flutter Journal of the American College of Cardiology. ,vol. 16, pp. 1639- 1648 ,(1990) , 10.1016/0735-1097(90)90314-F
Peter R Kowey, James T VanderLugt, John R Luderer, Safety and Risk/Benefit Analysis of Ibutilide for Acute Conversion of Atrial Fibrillation/Flutter American Journal of Cardiology. ,vol. 78, pp. 46- 52 ,(1996) , 10.1016/S0002-9149(96)00566-8
Raj R Makkar, Barbara S Fromm, Russell T Steinman, Marc D Meissner, Michael H Lehmann, Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs JAMA: The Journal of the American Medical Association. ,vol. 270, pp. 2590- 2597 ,(1993) , 10.1001/JAMA.270.21.2590
Pierre Abi-Mansour, Peter A. Carberry, Ronald J. McCowan, Richard W. Henthorn, George H. Dunn, Kimberly T. Perry, Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation American Heart Journal. ,vol. 136, pp. 632- 642 ,(1998) , 10.1016/S0002-8703(98)70010-9
RONALD W.F. CAMPBELL, PHARMACOLOGIC THERAPY OF ATRIAL FLUTTER Journal of Cardiovascular Electrophysiology. ,vol. 7, pp. 1008- 1012 ,(1996) , 10.1111/J.1540-8167.1996.TB00475.X